Michael D. Roth

ORCID: 0000-0003-2194-6578
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Immunotherapy and Immune Responses
  • Inflammatory Myopathies and Dermatomyositis
  • Cannabis and Cannabinoid Research
  • Immune Cell Function and Interaction
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Virus-based gene therapy research
  • Medical Imaging and Pathology Studies
  • Cancer Immunotherapy and Biomarkers
  • Dermatologic Treatments and Research
  • Neuroscience of respiration and sleep
  • Immune cells in cancer
  • Inflammatory mediators and NSAID effects
  • Asthma and respiratory diseases
  • RNA Interference and Gene Delivery
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Pancreatic function and diabetes
  • Voice and Speech Disorders
  • Diet, Metabolism, and Disease
  • Mast cells and histamine
  • Pericarditis and Cardiac Tamponade

University of California, Los Angeles
2016-2025

UCLA Health
2011-2024

Walter Reed National Military Medical Center
2024

Nippon Medical School
2023

The University of Texas Health Science Center at Houston
2023

Pulmonary and Critical Care Associates
1988-2018

McMaster University
2018

St. Joseph’s Healthcare Hamilton
2018

Scleroderma Foundation
2017

University of Michigan
2017

We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on lung function and health-related symptoms in patients with evidence active alveolitis scleroderma-related interstitial disease.At 13 clinical centers throughout United States, we enrolled 158 scleroderma, restrictive physiology, dyspnea, inflammatory disease examination bronchoalveolar-lavage fluid, thoracic high-resolution computed tomography, or both. Patients received (<...

10.1056/nejmoa055120 article EN New England Journal of Medicine 2006-06-21

Abstract Purpose: We previously reported that autologous dendritic cells pulsed with acid-eluted tumor peptides can stimulate T cell–mediated antitumor immune responses against brain tumors in animal models. As a next step vaccine development, phase I clinical trial was established to evaluate this strategy for its feasibility, safety, and induction of systemic intracranial T-cell patients glioblastoma multiforme. Experimental Design: Twelve were enrolled into multicohort dose-escalation...

10.1158/1078-0432.ccr-05-0464 article EN Clinical Cancer Research 2005-08-01

The Scleroderma Lung Study enrolled 158 patients with scleroderma-related interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although treatment-related benefits pulmonary function, skin scores, and patient-centered outcomes were demonstrated after 1 year therapy, the duration benefit beyond was unclear.A second follow-up performed to determine if these effects persisted stopping treatment.A detailed analysis data obtained over two years study...

10.1164/rccm.200702-326oc article EN American Journal of Respiratory and Critical Care Medicine 2007-11-05

<h3>Objective</h3> To assess survival and identify predictors of in patients with systemic sclerosis-interstitial lung disease (SSc-ILD) who participated the Scleroderma Lung Studies (SLS) I II. <h3>Methods</h3> SLS randomised 158 SSc-ILD to 1 year oral cyclophosphamide (CYC) vs placebo. II 142 CYC followed by placebo 2 years mycophenolate mofetil. Counting process Cox proportional hazard modelling identified variables associated long-term mortality Internal validation was performed using...

10.1136/annrheumdis-2018-213708 article EN Annals of the Rheumatic Diseases 2018-11-09

Abstract The ability of dendritic cells (DC) to initiate immune responses in naive T is dependent upon a maturation process that allows the develop their potent Ag-presenting capacity. Although immature DC can be derived vitro by treatment peripheral blood monocytes with GM-CSF and IL-4, additional signals such as those provided TNF-α, CD40 ligand, or LPS are required for complete maximum APC function. Because we recently found microbial lipoproteins activate through Toll-like receptor (TLR)...

10.4049/jimmunol.166.4.2444 article EN The Journal of Immunology 2001-02-15

Abstract The diverse roles of interferon-α (IFN-α) in regulating the immune response to infectious agents suggested that it might affect dendritic cell (DC) development. Peripheral blood mononuclear cells cultured with IFN-α and granulocyte-macrophage colony-stimulating factor (GM-CSF) developed a morphology expressed high levels class I II human leukocyte antigens (HLA), B7 costimulatory molecules, adhesion proteins, CD40. Elevated DC expression B7-2 HLA-DR was observed increasing...

10.1002/jlb.64.3.358 article EN Journal of Leukocyte Biology 1998-09-01

Abstract In this study, we show that Δ-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, suppresses host immune reactivity against lung cancer. two different weakly immunogenic murine cancer models, intermittent administration THC (5 mg/kg, four times/wk i.p. for 4 wk) led to accelerated growth tumor implants compared with treatment diluent alone. contrast our findings in immunocompetent mice, did not affect tumor-bearing SCID mice. The inhibitory cytokines, IL-10...

10.4049/jimmunol.165.1.373 article EN The Journal of Immunology 2000-07-01

Abstract Mammalian Toll-like receptors (TLRs) are required for cell activation by bacterial lipoproteins (bLP) and LPS. Stimulation of monocytes with bLP LPS results in a TLR-dependent induction immunomodulatory genes leading to the production pro-inflammatory cytokines. In this paper, we compared expression response TLRs on dendritic cells (DC). TLR2, but not TLR4, was detected peripheral blood DC, lymphoid tissue CD1a+ DC as well vitro monocyte-derived DC. Upon stimulation or LPS, produced...

10.4049/jimmunol.165.7.3804 article EN The Journal of Immunology 2000-10-01

Abstract Tumors produce a number of immunosuppressive factors that block the maturation CD34+ stem cells into dendritic (DC). We hypothesized tumors might also interfere with and/or function human monocyte-derived DC. In contrast to cells, we found CD14+ responded tumor culture supernatant (TSN) by increasing expression APC surface markers, up-regulating nuclear translocation RelB, and developing allostimulatory activity. Although displaying these characteristics mature DC, TSN-exposed DC...

10.4049/jimmunol.164.3.1269 article EN cc-by The Journal of Immunology 2000-02-01

Use of marijuana and cocaine is on the rise in United States. Although pulmonary toxicity from these drugs has occasionally been reported, little known about their effects lung microenvironment. We evaluated function alveolar macrophages (AMs) recovered lungs nonsmokers habitual smokers either tobacco, marijuana, or crack cocaine. AMs were deficient ability to phagocytose Staphylococcus aureus (p < 0.01). users also severely limited kill both bacteria tumor cells Studies using N...

10.1164/ajrccm.156.5.9704146 article EN American Journal of Respiratory and Critical Care Medicine 1997-11-01

Forty healthy young subjects, ages 20 to 49 yr, underwent videobronchoscopy, mucosal biopsy, and bronchial lavage evaluate the airway inflammation produced by habitual smoking of marijuana and/or tobacco. Videotapes were graded in a blinded manner for central erythema, edema, secretions using modified visual bronchitis index. The index scores significantly higher smokers (MS), tobacco (TS), combined marijuana/tobacco (MTS), than nonsmokers (NS). As pathologic correlate, biopsies evaluated...

10.1164/ajrccm.157.3.9701026 article EN American Journal of Respiratory and Critical Care Medicine 1998-03-01

Abstract The combination of granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) induces the growth antigen-presenting cells (APC) from adherent peripheral blood leukocytes. These have been characterized as dendritic (DC), yet many questions exist regarding their relationship to other DC populations nature progenitors. To address these issues, we utilized a immunomagnetic depletion, cell sorting, culture isolate four distinct APC populations; macrophages...

10.1002/jlb.59.2.208 article EN Journal of Leukocyte Biology 1996-02-01
Charlie Strange Marcy B. Bolster Michael D. Roth Richard M. Silver Arthur C. Theodore and 95 more Jonathan Goldin Philip J. Clements Joanie Chung Robert M. Elashoff Robert D. Suh Edwin A. Smith Daniel E. Furst Donald P. Tashkin Philip J. Clements Robert M. Elashoff Michael D. Roth Daniel E. Furst Ken J. Bulpitt Dinesh Khanna Wen Ling Joanie Chung Sherrie Viasco Mildred G. Sterz Lovlette Woolcock Xiaohong Yan Judy W.C. Ho Sarinnapha M. Vasunilashorn Irene Da Costa James R. Seibold D. Riley Judith K. Amorosa Vivien Hsu Deborah McCloskey Julianne E. Wilson John Varga Dean E. Schraufnagel Andrew C. Wilbur David Lapota Shiva Arami Patricia Cole-Saffold Robert W. Simms Peter Clarke Joseph H. Korn Kimberley Tobin M. Nuite Richard M. Silver Marcie Bolster Steve Schabel Edwin A. Smith June Arnold Katie Caldwell Michael Bonner Robert A. Wise Fred Wigley Barbara White Laura K. Hummers Mark E. Bohlman Albert J. Polito Gwen Leatherman E. Forbes Marie Daniel Virginia Steen Charles A. Read Cirrelda Cooper Sean Wheaton Anise Carey Adriana Ortiz Maureen D. Mayes Ed Parsley Sandra A. A. Oldham Tan Filemon Samantha Jordan Marilyn Perry Kari Connolly Jeffrey A. Golden Paul J. Wolters Richard Webb J. Michael Davis Christine Antolos Carla Maynetto Naomi F. Rothfield Mark L. Metersky Richard Cobb Macha Aberles F. Ingenito Elena Breen Kamal K. Mubarak J. L. Granda Joseph Silva Zora Injic Ronika Alexander Steven C. Springmeyer Steven Kirkland Jerry A. Molitor Richard Hinke Amanda Mondt Mitchell A. Olman Barri J. Fessler Colleen Sanders Louis W. Heck Tina Parkhill

Rationale: The presence of inflammatory cells on bronchoalveolar lavage is often used to predict disease activity and the need for therapy in systemic sclerosis–associated interstitial lung disease.Objectives: To evaluate whether cellularity identifies distinct subsets and/or predicts cyclophosphamide responsiveness.Methods: Patients underwent baseline high-resolution computed tomography as part a randomized placebo-controlled trial versus placebo (Scleroderma Lung Study) determine effect...

10.1164/rccm.200705-655oc article EN American Journal of Respiratory and Critical Care Medicine 2007-09-28

Patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) are thought to have the greatest decline in function (forced vital capacity [FVC]% predicted) early years after onset. The aim of this study was assess natural history FVC% predicted patients receiving placebo Scleroderma Lung Study and evaluate possible factors for cohort enrichment future therapeutic trials.Patients randomized receive (n=79) were divided into 3 groups based on duration SSc (0-2 years, 2-4 >4...

10.1002/art.30467 article EN Arthritis & Rheumatism 2011-05-25

To identify baseline characteristics of patients with scleroderma-related interstitial lung disease (SSc-ILD) that could serve as predictors the most favorable response to 12-month treatment oral cyclophosphamide (CYC).Regression analyses were retrospectively applied Scleroderma Lung Study data in order correlated absolute change forced vital capacity (FVC) (% predicted values) and placebo-adjusted % FVC over time (the CYC effect).Completion arm was associated a improvement 2.11% at 12...

10.1002/art.30438 article EN Arthritis & Rheumatism 2011-05-05

Background: The extent of lung involvement visualized by high-resolution computed tomography (HRCT) is a predictor decline in forced vital capacity (FVC) scleroderma-interstitial disease.Our objective was to evaluate the performance three different HRCT-defined staging systems Scleroderma Lung Study I (SLS I) over 1-year period. Methods:We assessed two visual semiquantitative scores: maximum fibrosis score (MaxFib, zone maximal involvement) and assessment total (TLI) as proposed Goh Wells.In...

10.1186/s13075-015-0872-2 article EN cc-by Arthritis Research & Therapy 2015-12-01
Suzanne Kafaja Philip J. Clements Holly Wilhalme Chi‐Hong Tseng Daniel E. Furst and 95 more Grace Hyun J. Kim Jonathan Goldin Elizabeth R. Volkmann Michael D. Roth Donald P. Tashkin Dinesh Khanna Ann Arbor Dinesh Khanna Los Angeles Philip J. Clements Donald P. Tashkin Robert M. Elashoff Jonathan Goldin Michael D. Roth Daniel E. Fürst Ken J. Bulpitt Wen Ling Joanie Chung Sherrie Viasco Millie Sterz Lovlette Woolcock Xiao Yan John S. Ho Sarinnapha M. Vasunilashorn Irene Da Costa James R. Seibold D. Riley J. K. Amorosa Vivien Hsu Deborah McCloskey James Wilson John Varga Dean E. Schraufnagel Andrew C. Wilbur David Lapota Shiva Arami Patricia Cole-Saffold Robert W. Simms A. Theodore Peter Clarke J H Korn Katy Tobin M. Nuite Richard M. Silver Marcy B. Bolster Charlie Strange Stephen I. Schabel Edwin A. Smith Jeanne Arnold Kathleen L. Caldwell Michael Bonner Robert A. Wise Fredrick M. Wigley Barbara White Laura K. Hummers Mark E. Bohlman Angelo Polito Gwen Leatherman E. Forbes Matěj Daniel Virginia Steen Cornelia D Read Christopher S. Cooper Sean Wheaton Andrew L. Carey A. Blandino Ortiz Maureen D. Mayes Ed Parsley Stephanie Oldham Tan Filemon S. Jordan Marilyn Perry K. Connolly Jeffrey A. Golden Paul J. Wolters Roger T. Webb J. Michael Davis Christine Antolos Carla Maynetto B. Fessler Mitchell A. Olman Caroline Sanders Louis W. Heck Tina Parkhill Naomi F. Rothfield Mark L. Metersky Richard Cobb Macha Aberles F. Ingenito Elizabeth C. Breen Maureen D. Mayes K.K. Mubarak J. L. Granda Joana Silva Zora Injic Ronika Alexander

To assess the reliability and minimal clinically important differences (MCID) for FVC% predicted in Scleroderma Lung Study I II.

10.1164/rccm.201709-1845oc article EN American Journal of Respiratory and Critical Care Medicine 2017-11-03

The Scleroderma Lung Study II (SLS II) demonstrated significant improvements in pulmonary function and dyspnea at 24 months compared with baseline when patients symptomatic scleroderma-related interstitial lung disease (SSc-ILD) were treated either cyclophosphamide for 1 year (followed another on placebo) or mycophenolate mofetil 2 years a randomized, double-blind clinical trial. Physiologic outcomes of SLS have been published previously.The aim the study was to assess changes from extent...

10.1513/annalsats.201802-079oc article EN Annals of the American Thoracic Society 2018-09-28

Study Design. Retrospective review of prospectively collected data. Objective. To assess the value deformity angular ratio (DAR, maximum Cobb measurement divided by number vertebrae involved) in evaluating severity spinal deformity, and predicting risk neurologic deficit posterior vertebral column resection (PVCR). Summary Background Data. Although literature has demonstrated that PVCR patients achieved excellent outcomes, it is still high neurologically. This study, to our knowledge,...

10.1097/brs.0000000000001547 article EN Spine 2016-03-08
Coming Soon ...